Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
Radiation Protection Dosimetry
|
January 18, 2014
Monte Carlo simulation of skull and knee voxel phantoms for the assessment of skeletal burden of low-energy photon emitters
M Y Nadar, D K Akar, H K Patni, et al.
Oncogene
|
December 11, 1997
Praja1, a novel gene encoding a RING-H2 motif in mouse development
L Mishra, R E Tully, S P Monga, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
April 29, 1998
Intratumoral cisplatin/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: a multicenter pilot study
H A Burris, C L Vogel, D Castro, et al.
American Journal of Clinical Oncology
|
August 24, 2000
Intratumoral therapy of cisplatin/epinephrine injectable gel for palliation in patients with obstructive esophageal cancer
S P Monga, R Wadleigh, A Sharma, et al.
Oncogene
|
November 17, 2005
Critical interactions between TGF-beta signaling/ELF, and E-cadherin/beta-catenin mediated tumor suppression
V Katuri, Y Tang, C Li, et al.
Oncogene
|
April 20, 2021
Correction: critical interactions between TGF-β signaling/ELF, and E-cadherin/β-catenin mediated tumor suppression
V Katuri, Y Tang, C Li, et al.
Journal of Biological Regulators and Homeostatic Agents
|
July 20, 2021
Contribution of Indian researchers in high impact periodontal journals: a bibliometric analysis of last three years
M Kumar, S Mishra, A K Srivastava, et al.
Oncogene
|
October 15, 2025
Editorial Expression of Concern: RING finger-dependent ubiquitination by PRAJA is dependent on TGF-ß and potentially defines the functional status of the tumor suppressor ELF
T Saha, D Vardhini, Y Tang, et al.
Oncogene
|
October 26, 2005
RING finger-dependent ubiquitination by PRAJA is dependent on TGF-beta and potentially defines the functional status of the tumor suppressor ELF
T Saha, D Vardhini, Y Tang, et al.
Oncogene
|
January 13, 2009
The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling
L Lin, R Amin, G I Gallicano, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
Radiation Protection Dosimetry
|
January 18, 2014
Monte Carlo simulation of skull and knee voxel phantoms for the assessment of skeletal burden of low-energy photon emitters
M Y Nadar, D K Akar, H K Patni, et al.
Oncogene
|
December 11, 1997
Praja1, a novel gene encoding a RING-H2 motif in mouse development
L Mishra, R E Tully, S P Monga, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
April 29, 1998
Intratumoral cisplatin/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: a multicenter pilot study
H A Burris, C L Vogel, D Castro, et al.
American Journal of Clinical Oncology
|
August 24, 2000
Intratumoral therapy of cisplatin/epinephrine injectable gel for palliation in patients with obstructive esophageal cancer
S P Monga, R Wadleigh, A Sharma, et al.
Oncogene
|
November 17, 2005
Critical interactions between TGF-beta signaling/ELF, and E-cadherin/beta-catenin mediated tumor suppression
V Katuri, Y Tang, C Li, et al.
Oncogene
|
April 20, 2021
Correction: critical interactions between TGF-β signaling/ELF, and E-cadherin/β-catenin mediated tumor suppression
V Katuri, Y Tang, C Li, et al.
Journal of Biological Regulators and Homeostatic Agents
|
July 20, 2021
Contribution of Indian researchers in high impact periodontal journals: a bibliometric analysis of last three years
M Kumar, S Mishra, A K Srivastava, et al.
Oncogene
|
October 15, 2025
Editorial Expression of Concern: RING finger-dependent ubiquitination by PRAJA is dependent on TGF-ß and potentially defines the functional status of the tumor suppressor ELF
T Saha, D Vardhini, Y Tang, et al.
Oncogene
|
October 26, 2005
RING finger-dependent ubiquitination by PRAJA is dependent on TGF-beta and potentially defines the functional status of the tumor suppressor ELF
T Saha, D Vardhini, Y Tang, et al.
Oncogene
|
January 13, 2009
The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling
L Lin, R Amin, G I Gallicano, et al.
Page
of 8